2 Tiger Global Johnson & Johnson Trades
Tiger Global started to build up the position in Johnson & Johnson in Q1 2009. Since then they sold 633 Thousand shares. The investor sold all their shares in Q2 2009 and doesn't own any shares in Johnson & Johnson anymore.
Avg closing price
Price range
Sold -633 Thousand shares
Q2 2009
Avg closing price
$54.15
Price range
$50.65
-
$56.96
New holding (+633 Thousand shares)
Q1 2009
Avg closing price
$54.70
Price range
$46.60
-
$60.65
News about Johnson & Johnson and Tiger Global
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Johnson & Johnson submits supplemental Biologics License Application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis
Submission is supported by data from the Phase 3 QUASAR program, which showed a significantly greater percentage of patients with moderately to severely acti...
Global Orphan Drugs Market Research Report 2023: Market to Reach $415.2 Billion by the End of 2028 - Premium Pricing of Orphan Drugs and Increasing Collaborations/Licensing Agreements Bolsters Growth
![EVERYONE Needs To Know What To Buy in 2024 [Video]](https://cloud.iexapis.com/v1/news/image/1nxeLWGoCZaSNGie29jowkDNULNYkUnIhooDmDmWeqLZ)
EVERYONE Needs To Know What To Buy in 2024 [Video]
My 100% FREE Financial Education Course: https://themoneygps.com/compassInterest rate cuts and their historical impact on financial markets, drawing key insi...